Esteban Romero-Rubio
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19
Journal: Reumatologia clinica
Published: March 25, 2020
Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19
Journal: Reumatologia clinica
Published: March 25, 2020
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients.
Journal: Seminars in arthritis and rheumatism
Published: February 12, 2020
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.
Journal: Rheumatology international
Published: May 07, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 29, 2018
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure.
Journal: Reumatologia clinica
Published: January 16, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
Journal: Ophthalmology
Published: November 05, 2017
Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project.
Journal: Reumatologia clinica
Published: October 20, 2017
Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients.
Journal: Seminars in arthritis and rheumatism
Published: December 02, 2015
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 08, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026